Ryan Merkow to Combined Modality Therapy
This is a "connection" page, showing publications Ryan Merkow has written about Combined Modality Therapy.
Connection Strength
0.480
-
Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative. J Surg Oncol. 2022 Mar; 125(4):560-563.
Score: 0.151
-
Utilization and Treatment Patterns of Cytoreduction Surgery and Intraperitoneal Chemotherapy in the United States. Ann Surg Oncol. 2020 Jan; 27(1):214-221.
Score: 0.128
-
Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer. Ann Surg. 2013 Dec; 258(6):847-53.
Score: 0.087
-
National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection. Ann Surg Oncol. 2020 Mar; 27(3):909-918.
Score: 0.033
-
Assessment of advanced gastric cancer management in the United States. Ann Surg Oncol. 2013 Jul; 20(7):2124-31.
Score: 0.021
-
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S500-8.
Score: 0.021
-
Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement. Ann Surg Oncol. 2012 Nov; 19(12):3659-67.
Score: 0.020
-
Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States. Ann Surg Oncol. 2013 Feb; 20(2):362-70.
Score: 0.020